The Contrasting Medicines Regulatory Environments of China and the Western World Peter J. HarrisIan C. Shaw Editorial 16 October 2015 Pages: 319 - 322
Global Implications of the EU’s Pharmacovigilance System Master File Requirements: Newly Developed Decision Trees to Distinguish Different Study Types Stefan T. KaehlerNeil MintonJohn Freeman Leading Article 13 October 2015 Pages: 323 - 329
Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US Chi Y. BahkMelanie GoshgarianNabarun Dasgupta Original Research Article Open access 05 August 2015 Pages: 331 - 340
Untangling the Complexity of Funding Recommendations: A Comparative Analysis of Health Technology Assessment Outcomes in Four European Countries Karin H. CerriMartin KnappJose-Luis Fernandez Original Research Article 11 September 2015 Pages: 341 - 359
Drugs in Clinical Development for Fungal Infections: Summary and Table Adis Profile Summary 13 November 2015 Pages: 361 - 363
